Fact CheckerSign in

NCT06773364RecruitingPhase 3

Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

An Investigator Initiated and Conducted, Prospective, Multicentre, Randomised Outcome-blinded Study of Pre-hospital Initiated Levetiracetam and Headposition in Patients With Presumed Acute Stroke

Source: ClinicalTrials.gov · Last updated 22 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is an investigator initiated and conducted, multicentre, ambulance-delivered, prospective, randomised, open-label, blinded outcome (PROBE) study. EAST aims to evaluate the effects of pre-hospital levetiracetam and different head positions initiated in ambulance settings on the functional outcome of participants assessed at 90 days.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
2423 (estimated)
First submitted
2 Jan 2025
Start date
30 Apr 2025
Primary completion date
31 Dec 2028
Lead sponsor
Shanghai East Hospital
Diseases
Stroke
NCT number
NCT06773364

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 2423
  • From 30 Apr 2025 to the primary completion date, 31 Dec 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • severe co-morbid disease (e.g. cancer, chronic airflow disease, severe dementia, severe heart failure, pre-existing disability \[needing help with everyday activities\]);
  • history of epilepsy or seizure at onset;
  • clear indications or contraindications (allergies) for levetiracetam;

Lab values

  • hypoglycaemia (glucose \<2.8mmol/L);

Other

  • coma (no response to painful stimulation);
  • recent head injury;
  • lactating women;
  • clear indications for a particular head position or situations where either head position cannot be maintained (such as severe vomiting and inability to lie down, severe obesity with fatigue and difficulty sitting up, etc.).

Who the study is looking for

  • Adults (age ≥18 years);
  • Acute condition that is presumed due to acute stroke, defined on the FAST (Face, Arm, Speech, Time) screen (score ≥2 with an arm deficit);
  • Time ≤2 hours from last seen well;
  • Able to provide brief consent (if a waver of consent not approved by ethics committee).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai East Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting
Si County People's Hospital
Coordinator of this site? Confirm its status
SuzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.